Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-02-23

Clinical Trial Update: Colchicine in Atrial Fibrillation to Prevent Stroke [Phase 3]

View source ↗

Summary

Phase 3 trial update on colchicine for preventing stroke in patients with atrial fibrillation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • COLCHICINE (Colchicine)

Snippet

Sponsor: Population Health Research Institute | Conditions: Atrial Fibrillation, Stroke | Phase 3 | Status: COMPLETED